Plasmid-encoded AmpC type β-lactamase from a clinical isolate of P. mirabilis in Tunisia;β-lactamase plasmidique (AmpC) chez un Proteus mirabilis en Tunisie

Medecine et Maladies Infectieuses

Volumn 29, Issue 6, 1999, Pages 415-417

  Ben Redjeb, S ^a   Ben Hassen, A ^a   Verdet, C ^b   Arlet, G ^b   Bouabdallah, F ^a   Philippen, A ^c  

^a CHARLES NICOLLE HOSPITAL   (Tunisia)

^b SAINT LOUIS HOSPITAL   (France)

^c Institut Cochin   (France)

Author keywords

Ampc type lactamase; Plasmid; Proteus mirabilis

Indexed keywords

BACTERIAL ENZYME; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEPHALOSPORINASE;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CONJUGATION; BACTERIUM ISOLATE; CASE REPORT; CITROBACTER FREUNDII; CONTROLLED STUDY; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; FEMALE; GENE AMPLIFICATION; HUMAN; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEUS MIRABILIS; URINARY TRACT INFECTION;

EID: 0032748117     PISSN: 0399077X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0399-077x(99)80050-x     Document Type: Article

References (10)

1. Medeiros AA. Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics. Clin Infect Dis 1997 ; 24 Suppl : 19-45.
2. Ben Redjeb S, Ben Yaghlane H, Boujnah A, Philippen A, Labia R. Synergy between clavulanic acid and newer β-lactams on nine cli-nical isolates of Klebsiella pneumoniae, Escherichia coli and Salmonella typhimurium resistant to third generation cephalosporins, J Antimicrob Chemother. 1988 ; 21 : 263-6.
3. Papanicolau GA, Medeiros AA, Jacoby GA. Novel plasmid-mediated lactamase (MIR-1) conferring resistance to oxymino- and a-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 1990 ; 34 : 2200-9.
4. Philippen A, Arlet G. Les céphalosporinases plasmidiques de type AmpC. Lettre Infectiol 1997 ; 12 : 26-8.
5. Ben Hassen A, Fournier G, Kechrid A, Fendri C, Ben Redjeb S. Philippon A. Résistance enzymatique au céfotaxime chez cinquante six souches de Klebsiella spp., Escherichia coli et Salmonella spp. dans un hôpital tunisien (1984-1988). Pathol Biol 1990 ; 38 : 460-9.
6. Koeck JL, Arlet G, Philippon A, Basmaciogullari S, Buisson Y, Cavallo JD. Another plasmid-mediated CMY-2 β-lactamase in an clinical isolate of Salmonella senftenberg. FEMS Microbiol Letters 1997 ; 152 : 255-60.
7. Bret L, Chanal-Claris C, Sirot D, Chaibi EB, Labia R, Sirot. Chromosomally encoded ampC-type β-lactamase in a clinical isolate of Proteus mirabilis. Antimicrob Agents Chemother 1998 ; 42 : 1110-4.
8. Bradford PA, Urban C, Mariano N, Rahal J, Bush K. Imipenem resistance in clinical isolates of Klebsiella pneumoniae; results from ACT-1, a plasmid-mediated AmpC β-lactamase combined with loss of an outer membrane porin protein. Antimicrob Agents Chemother 1997 ; 41 : 563-9.
9. Marchese A, Arlet G, Schito GC, Lagrange PH, Philippon A. Characterization of FOX-3, an AmpC-type plasmid-mediated β-lactamase from italian Klebsieila oxytoca isolate. Antimicrob Agents Chemother 1998 ; 42 : 464-7.
10. Tzouvelekis LS, Tzelepi E, Mentis AF. Nucleotide sequence of a plasmid mediated cephalosporinase gene (blaLAT-1) found in Klebsiella pneumoniae. Antimicrob Agents Chemother 1994 ; 38 : 2207-9.